pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,293 catalysts · 3,153 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 46 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-07×clear all
type
  • 8k filing3,153
  • earnings577
  • grant184
  • phase 2 completion172
  • drug shortage133
  • approval128
phase 1 completion
73
  • device 510k68
  • phase 2 initiation62
  • recall52
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 13, 2026

    50
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medical Care RTG, LLC, Manufactured by: Fresenius Kabi, Unit of Use NDC: 65219-282-01, Unit of Sale NDC Number: 65219-282-10. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoViatris, Inc. recall (Cls II)Viatris Inc

    Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 — Reason: Failed Dissolution Specifications — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoPreferred Pharmaceuticals, Inc. recall (Cls II)InMed Pharmaceuticals Inc.

    Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFagron Compounding Services recall (Cls II)Baxter Healthcare Corp

    norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFagron Compounding Services recall (Cls II)Revalesio Corp

    Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoGE Healthcare Ireland Limited recall (Cls II)Amneal Pharmaceuticals, Inc.

    GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. — Reason: Presence of particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

    0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026recall120d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 15, 2026drug shortage120d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoSodium Acetate Injection shortage — Milla PharmaceuticalsMilla Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoClonazepam Tablet shortage — Cheplapharm Arzneimittel GmbHCHEPLAPHARM Arzneimittel GmbH

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoMethotrexate Sodium Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoLisdexamfetamine Dimesylate Capsule shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Capsule

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoMidazolam Hydrochloride Injection shortage — Avet Pharmaceuticals, Inc.AVEO Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoAtropine Sulfate Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoClonazepam Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Sunrise Pharmaceutical, Inc.Sunrise Pharmaceutical Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoTiagabine Hydrochloride Tablet shortage — Teva Pharmaceuticals USA, Inc.Teva Pharmaceuticals USA Inc

    Status: To Be Discontinued. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoQuinapril/Hydrochlorothiazide Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoCarboplatin Injection shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoClonazepam Tablet shortage — Accord Healthcare Inc.Accord Healthcare Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoFurosemide Injection shortage — Avet Pharmaceuticals, Inc.AVEO Pharmaceuticals Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoBumetanide Injection shortage — MSN Laboratories Private LimitedEdenbridge Pharmaceuticals LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Lannett Company, Inc.Lannett Co Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoAtropine Sulfate Injection shortage — American Regent, Inc.American Regent Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoQuinapril Hydrochloride Tablet shortage — Aurobindo Pharma USAAurobindo Pharma USA Inc

    Status: Current. Reason: not specified. Form: Tablet

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoSodium Bicarbonate Injection shortage — Exela Pharma Sciences, LLCExela Pharma Sciences LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoSterile Water Injection shortage — Medefil, Inc.Medefil Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoAtropine Sulfate Injection shortage — Medefil, Inc.Medefil Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026drug shortage120d agoTechnetium TC-99M Pyrophosphate Kit Injection shortage — Curium US LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 15, 2026grant120d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Project 4New York University

    AI grant. $344,099. PI: Vasishta Tatapudi

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoPENNSYLVANIA STATE UNIVERSITY, THE — Project 2: Infrastructure Development

    AG grant. $542,766. PI: Martin J Sliwinski

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoMONTANA STATE UNIVERSITY - BOZEMAN — Defining Staphylococcus aureus SaeR/S-mediated mechanisms that Impact Human N...

    GM grant. $211,579. PI: Madison Martin Collins

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — Street PrEP: Expanding a Low-Barrier PrEP Delivery Model Among People Who Use...

    DA grant. $588,669. PI: Albert Ying-Hwa Liu

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoMASSACHUSETTS GENERAL HOSPITAL — Optimizing High-Resolution MRI for Analyzing Perivascular Space Dynamics and ...Massachusetts General Hospital

    AG grant. $670,530. PI: Xiaoqing Alice Zhou

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — Is restrictive eating behavior in anorexia nervosa short-sighted? An experime...

    MH grant. $450,175. PI: Emily Caitlin Lloyd

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoUNIVERSITY OF CHICAGO — Natural variation of embryo development across the insect order of flies

    GM grant. $480,083. PI: URS C Schmidt-Ott

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoSTANFORD UNIVERSITY — T cell Contributions to Neointima Formation in Pulmonary HypertensionStanford University

    HL grant. $165,888. PI: Adam Michael Andruska

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoMIAMI UNIVERSITY OXFORD — FOXE3 in Creating Lens Chromatin Architecture and Transcriptional Identity

    EY grant. $467,969. PI: MICHAEL L ROBINSON

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoUNIVERSITY OF WASHINGTON — Optimizing Mindfulness Practice for Pain in People with Multiple SclerosisUniversity of Washington

    AT grant. $164,268. PI: Erin G. Mistretta

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Gathering Evidence for Patient-Informed Clinical Care of Early Female Puberty

    HD grant. $172,623. PI: Camilia Kamoun

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoUNIVERSITY OF PENNSYLVANIA — 3D MRI Method for CMRO2 Mapping of the Brain in DementiaUniversity of Pennsylvania

    AG grant. $429,498. PI: Felix W Wehrli

    full page →nih reporter ↗
    ›Apr 15, 2026grant120d agoUNIVERSITY OF PENNSYLVANIA — The Maternal Immune Axis Programs Fetal CorticogenesisUniversity of Pennsylvania

    MH grant. $689,249. PI: Yeong Shin Yim

    full page →nih reporter ↗
    ← prev
    page 8 of 86
    next →
    $VTRS16.23-0.31%
    $AMRX17.10-4.36%
    $TERN52.95-0.03%
    $INM1.4309-1.99%
    $TERN52.95-0.03%